This is a working overview of MOD GRF(1-29), written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-12-09 and is reviewed periodically as new material appears.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
| Property | Value | Notes |
|---|---|---|
| Molecular weight, DAC form | About 3647 Da | Varies with salt form |
| Molecular weight, non-DAC form | About 3358 Da | MOD GRF(1-29) |
| Solubility class | Water soluble | Also dissolves in polar solvents |
| Reported half-life, DAC form | About five to eight days | Values from human studies |
| Common synonyms | CJC-1295; MOD GRF(1-29) | Name depends on variant |
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
=== Diabetes insipidus === In 1913, researchers in Italy (A. Farini and B. Ceccaroni) and Germany (R. Von den Velden) reported the anti-diuretic effect of the substance extracted from the posterior lobe of the pituitary gland. The hormone responsible for this effect was later isolated and named vasopressin. Even while the pathophysiology of diabetes insipidus was being further clarified, these findings made possible a relatively simple and effective treatment such that physicians could begin to control the disease. Various preparations of the extract were produced and made commercially available by the pharmaceutical industry through the 20th century. In 1928, Oliver Kamm and his colleagues posited two active principles in the pituitary extract: one with antidiuretic and pressor properties (vasopressin), and another with uterotonic properties (oxytocin). In a series of landmark achievements between 1947 and 1954 which culminated in a Nobel Prize in Chemistry (1955), Vincent du Vigneaud isolated, sequenced, and synthesized oxytocin and vasopressin. Today, synthesized and modified vasopressin is used to treat the condition.
== Medical use == Both T3 and T4 are used to treat thyroid hormone deficiency (hypothyroidism). They are both absorbed well by the stomach, so they can be given orally. Levothyroxine is the chemical name of the manufactured version of T4, which is metabolised more slowly than T3 and hence usually needs only once-daily administration. Natural desiccated thyroid hormones are derived from pig thyroid glands, and are a "natural" hypothyroid treatment containing 20% T3 and traces of T2, T1 and calcitonin. Also available are synthetic combinations of T3/T4 in different ratios (such as liotrix) and pure-T3 medications (INN: liothyronine). Levothyroxine sodium is usually the first course of treatment tried. Some patients report better outcomes with desiccated thyroid hormone; however, this is based on anecdotal evidence, and clinical trials have not shown any benefit over biosynthetic forms. Thyroid tablets are reported to have different effects, which can be attributed to the difference in torsional angles surrounding the reactive site of the molecule. Thyronamines have no medical usages yet, though their use has been proposed for controlled induction of hypothermia, which causes the brain to enter a protective cycle and can be useful in preventing damage during ischemic shock. Synthetic thyroxine was first successfully produced by Charles Robert Harington and George Barger in 1926.
CNS excitation: nervousness, agitation, anxiety, apprehension, tingling around the mouth (circumoral paraesthesia), headache, hyperesthesia, tremor, dizziness, pupillary changes, psychosis, euphoria, hallucinations, and seizures CNS depression with heavier exposure: drowsiness, lethargy, slurred speech, hypoesthesia, confusion, disorientation, loss of consciousness, respiratory depression, and apnoea. Cardiovascular: hypotension, bradycardia, arrhythmias, flushing, venous insufficiency, increased defibrillator threshold, edema, and/or cardiac arrest – some of which may be due to hypoxemia secondary to respiratory depression. Respiratory: bronchospasm, dyspnea, respiratory depression or arrest Gastrointestinal: metallic taste, nausea, vomiting, agita, and diarrhea Ears: tinnitus Eyes: local burning, conjunctival hyperemia, corneal epithelial changes/ulceration, diplopia, visual changes (opacification) Skin: itching, depigmentation, rash, urticaria, edema, angioedema, bruising, inflammation of the vein at the injection site, irritation of the skin when applied topically Blood: methemoglobinemia Allergy ADRs associated with the use of intravenous lidocaine are similar to the toxic effects of systemic exposure above. These are dose-related and more frequent at high infusion rates (≥3 mg/min). Common ADRs include headache, dizziness, drowsiness, confusion, visual disturbances, tinnitus, tremor, and/or paraesthesia.
In this case, the three substrates of this enzyme are cyanidin, reduced nicotinamide adenine dinucleotide phosphate (NADPH), and a proton. It converts them to (–)-epicatechin and oxidised NADP+. The enzyme from the legume Medicago truncatula can use nicotinamide adenine dinucleotide as an alternative cofactor. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-CH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is flavan-3-ol:NAD(P)+ oxidoreductase. Other names in common use include AtANR, and MtANR. This enzyme participates in flavonoid biosynthesis.
=== Academic education === There are three universities in Kiel (classical, budget 167.1 M€), Lübeck (medicine, budget 80.8 M€) and Flensburg (pedagogical, 37.4 M€). Six public Universities of Applied Sciences exist in Wedel, Altenholz, Flensburg, Heide, Kiel, and Lübeck. There is the Conservatory in Lübeck and the Muthesius Academy of Fine Arts in Kiel. There are also three private institutions of higher learning.
Sources: en.wikipedia.org
=== Molecular biology laboratories === Polyacrylamide is also often used in molecular biology applications as a medium for electrophoresis of proteins and nucleic acids in a technique known as PAGE. PAGE was first used in a laboratory setting in the early 1950s. In 1959, the groups of Davis and Ornstein and of Raymond and Weintraub independently published on the use of polyacrylamide gel electrophoresis to separate charged molecules. The technique is widely accepted today, and remains a common protocol in molecular biology labs. Acrylamide has other uses in molecular biology laboratories, including the use of linear polyacrylamide (LPA) as a carrier, which aids in the precipitation of small amounts of nucleic acids (DNA and RNA). Many laboratory supply companies sell LPA for this use. In addition, under certain conditions, it can be used to selectively precipitate only RNA species from a mixture of nucleic acids.
== Personal life == Samberg is married to musician Joanna Newsom. He described himself as her "superfan", and they met at one of her concerts in 2006. After five years of dating, Samberg proposed to her in February 2013, and they married on September 21, 2013, in Big Sur, California, with Saturday Night Live co-star Seth Meyers serving as Samberg's groomsman. In March 2014, Samberg and Newsom purchased the Moorcrest estate in the Beachwood Canyon area of Los Angeles, California, which was associated with various historical figures: in the 1920s, it was owned by the parents of actress Mary Astor; prior to that, Charlie Chaplin rented it. The couple also owns a home in Manhattan's West Village. They announced the birth of their daughter on August 8, 2017. The birth of their second child, a son, was announced by the Lonely Island's Jorma Taccone in February 2023. Samberg, who grew up in the East Bay, is a fan of the Oakland Athletics and the Golden State Warriors. Samberg was raised in a Jewish family, but considers himself "not particularly religious".
Rockefeller University – then the Rockefeller Institute for Medical Research (established by Senior); Colonial Williamsburg (John Jr., Abby); Riverside Church (John Jr.); International House of New York (John Jr.); General Education Board – later the International Education Board (Senior); China Medical Board (John Sr., John Jr.); Bureau of Social Hygiene (John Jr.); Industrial Relations Counselors (John Jr.). John III was at one time a member of the Council on Foreign Relations, the Foreign Policy Association and the Institute of Pacific Relations, as well as being on the board of directors of Princeton University. In late 1950, he accompanied secretary of state John Foster Dulles and Douglas MacArthur on a trip to Japan to conclude a peace treaty, during which time he consulted with many Japanese leaders in practically every important sphere of that country's life. He was a prominent third-generation family philanthropist in his own right and founder of the Asia Society, the major institution he established in 1956 to foster greater cooperation between Asia and the United States. He also founded the Population Council in 1952, and a reconstituted Japan Society. In addition, he set up the United Negro College Fund for the ongoing education of African Americans, carrying on the family tradition in this area with his grandfather's funding of the education of black women at Spelman College in Atlanta. He was on his father's Advisory Committee in the family office, Room 5600.
Carboxylation of these vitamin K-dependent Gla-proteins, besides being essential for the function of the protein, is also an important vitamin recovery mechanism since it serves as a recycling pathway to recover vitamin K from its epoxide metabolite (KO) for reuse in carboxylation. Several human Gla-containing proteins synthesized in several different types of tissue have been discovered:
Sources: en.wikipedia.org
Only 1–2% of Alzheimer's cases are inherited due to autosomal dominant mutations, as Alzheimer's disease is substantially polygenic. When autosomal dominant variants cause the disease, it is known as early-onset familial Alzheimer's disease, which is rarer and tends to progress more rapidly. Less than 5% of sporadic Alzheimer's disease have an earlier onset, and early-onset Alzheimer's is about 90% heritable. Familial Alzheimer's disease usually implies two or more persons affected in one or more generations. Early onset familial Alzheimer's disease can be attributed to mutations in one of three genes: those encoding amyloid-beta precursor protein (APP) and presenilins PSEN1 and PSEN2. Most mutations in the APP and presenilin genes increase the production of a small protein called amyloid beta (Aβ)42, which is the main component of amyloid plaques. Some of the mutations merely alter the ratio between Aβ42 and the other major forms—particularly Aβ40—without increasing total Aβ levels in the brain. Two other genes associated with autosomal dominant Alzheimer's disease are ABCA7 and SORL1. Alleles in the TREM2 gene have been associated with a three to five times higher risk of developing early-onset Alzheimer's disease. A Japanese pedigree of early-onset familial Alzheimer's disease was found to be associated with a deletion mutation of codon 693 of APP. This mutation and its association with Alzheimer's disease was first reported in 2008, and is known as the Osaka mutation. Only homozygotes with this mutation have an increased risk of developing Alzheimer's disease.
=== Radiotherapy === Radiotherapy is used mostly for focal type of NM due to the nature of damage and success rate associated with the treatment. Radiotherapy targets the tumor and destroys the collective tissues of cancerous cells. Proton therapy, which delivers radiation via charged protons rather than X-rays, has recently shown promise as an effective treatment for leptomeningeal disease.
Eric Stephen Schmitt (born June 20, 1975) is an American attorney and politician serving since 2023 as the junior United States senator from Missouri. A member of the Republican Party, Schmitt served as the 46th state treasurer of Missouri from 2017 to 2019 and as the 43rd Missouri attorney general from 2019 to 2023. Schmitt began his political career as an alderman for Glendale, Missouri. From 2009 to 2017, he represented the 15th district in the Missouri Senate, during which he sponsored major reductions in the state income tax and franchise tax, and expanded benefits and tax exemptions for disabled citizens. As a state senator, Schmitt also led a bipartisan effort in response to the Ferguson unrest to successfully eliminate traffic ticket quotas and limit local revenues from non-traffic fines. In 2016, Schmitt was elected State Treasurer of Missouri. In 2018, Governor Mike Parson appointed Schmitt Missouri Attorney General. He was elected to a full four-year term as attorney general in 2020. As attorney general, he filed or joined lawsuits seeking to invalidate the Affordable Care Act, challenge the results of the 2020 presidential election (in Texas v. Pennsylvania), and, on 25 occasions, oppose the policies of the Joe Biden administration. He also sued school districts and municipalities for implementing mask requirements during the COVID-19 pandemic and sued the government of China and Chinese Communist Party for their alleged role in the pandemic. In 2022, Schmitt was elected to the U.S. Senate, defeating Democratic nominee Trudy Busch Valentine.
Sources: en.wikipedia.org
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.
The DAC form carries a maleimide group that binds albumin and extends circulation time. The non-DAC form lacks this group and clears much faster. Both share the same receptor-binding core.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Activation raises cyclic AMP and promotes growth hormone release. Normal feedback pathways remain part of the response.
Chromatography reports how much material elutes as a single peak but does not confirm what that material is. Mass spectrometry supplies the molecular mass, which is characteristic of a given sequence and its modifications. Together the two methods support both a purity figure and an identity claim.